Lombard et Medot (XPAR:MLCAC) Research & Development: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLCAC Lombard et Medot XPAR:MLCAC
46 GF Score
Price €15.00
GF Value €11.85
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lombard et Medot Research & Development?

Lombard et Medot XPAR:MLCAC -3.23% 46 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates XPAR:MLCAC with a GF Score™ of 46/100 and a GF Value™ of €11.85 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Lombard et Medot's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Lombard et Medot  (XPAR:MLCAC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lombard et Medot Research & Development Related Terms

Lombard et Medot Research & Development Historical Data

* Premium members only.

The historical data trend for Lombard et Medot's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lombard et Medot Research & Development Chart

Lombard et Medot Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Lombard et Medot Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XPAR:MLCAC
46GF Score
Lombard et Medot XPAR:MLCAC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lombard et Medot Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Lombard et Medot (XPAR:MLCAC) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Lombard et Medot and its competitors.
Is Lombard et Medot's Research & Development too high?
Lombard et Medot's current Research & Development is €0.00 Mil. Overall, Lombard et Medot has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lombard et Medot's Research & Development compare to BF.B?
Lombard et Medot's Research & Development of €0.00 Mil can be compared against companies in the Beverages - Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Beverages - Alcoholic company?
A good Research & Development depends on the Beverages - Alcoholic industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Lombard et Medot and its competitors. Lombard et Medot's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lombard et Medot stock overvalued right now?
Based on GuruFocus' analysis, Lombard et Medot (XPAR:MLCAC) is currently considered Modestly Overvalued. The stock's GF Value™ is €11.85, compared to a current price of €15.00 — trading 26.6% above its estimated fair value. The current Research & Development is €0.00 Mil. Lombard et Medot's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Lombard et Medot (XPAR:MLCAC), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lombard et Medot (XPAR:MLCAC) Overvalued in 2026?

Based on GuruFocus' analysis, Lombard et Medot stock appears to be overvalued. The current stock price of €15.00 is trading 26.6% above its estimated GF Value™ of €11.85. GuruFocus considers Lombard et Medot to be Modestly Overvalued.

Key valuation signals for XPAR:MLCAC:

  • Research & Development: €0.00 Mil
  • GF Value™: €11.85 vs. price of €15.00 (26.6% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the XPAR:MLCAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lombard et Medot Business Description

Address 1 Rue Des Cotelles PB 118, Epernay, FRA, 51204
Lombard et Medot operates in brewers industry. The company is engaged in the manufacturing, packaging, and distribution of champagne in France and other parts of the world.
46GF Score

Get the complete analysis for XPAR:MLCAC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.00
Price
€11.85
GF Value